NCT05992220
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Asan Medical Center Seoul, South Korea
Clinical trial condition
Hepatocellular Cancer
Explore clinical trials studying Hepatocellular Cancer. Study availability and eligibility vary by location and protocol.
57 public trials
14 recruiting studies
Hepatocellular Cancer trial results
NCT05185505
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Houston Methodist Research Institute Houston, Texas, United States
NCT03787056
- Conditions
- Adnexal Diseases, Astrocytoma, B-cell Lymphoma, +89 more
- Locations
-
- Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST Bron, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse Lyon, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot Lyon, France
- Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse Lyon, France
NCT03253536
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +7 more
- Locations
-
- Department of Radiation Oncology, University Hospital, LMU Munich Munich, Bavaria, Germany
Not yet recruiting
Patients With Hepatocellular Carcinoma (HCC)
NCT07690683
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
Not yet recruiting
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
NCT07110233
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Not yet recruiting
A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer
NCT06935175
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
- Locations
-
- Shanghai Zhongshan Hospital Shanghai, China
Active, not recruiting
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
NCT03937830
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, not recruiting
SIRT With Tremelimumab and Durvalumab for Resectable HCC
NCT05701488
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
NCT02954094
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
- Locations
-
- Banner University Medical Center Phoenix, Arizona, United States
- University of Arkansas Little Rock, Arkansas, United States
- University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford University Palo Alto, California, United States